Dogwood Therapeutics (DWTX) Stock Price, Quote, News & History

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibro...

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga

Benzinga

Dogwood Therapeutics Inc (DWTX) Stock Price, Quote, News & History

Key Statistics

Recent Dogwood Therapeutics Inc News

PROHC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

PRODogwood Reaches 50% Enrollment In Ongoing Halneuron Phase 2b Trial

PROHC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Dogwood Therapeutics (DWTX) stock?

Who are Dogwood Therapeutics (DWTX) competitors?

What is the forecast, or price target, for Dogwood Therapeutics (DWTX) stock?

What is the current price for Dogwood Therapeutics (DWTX)?

Does Dogwood Therapeutics (DWTX) pay a dividend?

When is Dogwood Therapeutics (NASDAQ:DWTX) reporting earnings?

Is Dogwood Therapeutics (DWTX) going to split?

What sector and industry does Dogwood Therapeutics (DWTX) operate in?

People Also Watch

Key Statistics

Recent Dogwood Therapeutics Inc News

PROHC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

PRODogwood Reaches 50% Enrollment In Ongoing Halneuron Phase 2b Trial

PROHC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

Compare

FAQ

How do I buy Dogwood Therapeutics (DWTX) stock?

Who are Dogwood Therapeutics (DWTX) competitors?

What is the forecast, or price target, for Dogwood Therapeutics (DWTX) stock?

What is the current price for Dogwood Therapeutics (DWTX)?

Does Dogwood Therapeutics (DWTX) pay a dividend?

When is Dogwood Therapeutics (NASDAQ:DWTX) reporting earnings?

Is Dogwood Therapeutics (DWTX) going to split?

What sector and industry does Dogwood Therapeutics (DWTX) operate in?

People Also Watch

Bulls vs Bears

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

PRO
Dogwood Reaches 50% Enrollment In Ongoing Halneuron Phase 2b Trial

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

PRO
Dogwood Reaches 50% Enrollment In Ongoing Halneuron Phase 2b Trial

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target